Cognitive behavioral therapy CBT) has a good track record as a first-line treatment for common psychological problems. As is the case with all therapy, CBT has traditionally been delivered to clients ...
Everyday Health on MSN
How to take care of your mental health on a GLP-1
Starting a GLP-1? Therapists share practical strategies for protecting your mental health, navigating body changes, and ...
Baller Alert on MSN
Lil Uzi Vert sought treatment for addiction, then their private therapy session allegedly hit the timeline
Lil Uzi Vert is moving a deeply personal recovery issue into court after accusing a California rehab facility employee of secretly recording part of a private treatment session and allowing […] The ...
Trace Ritterhouse’s life changed in an instant. A devastating motor vehicle accident in rural Stafford County left him with ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness. Reading time 3 minutes Buckle up. High-stakes human testing has now begun on a ...
Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Miles, age 2, is one of the first patients at Boston Children's hospital to receive gene ...
Just before the holidays in 2025, Julie Hart felt stuck. A nagging problem she had struggled with for years left her ruminating all day and questioning nearly everything she had ever said, done or ...
A new therapy for genetic hearing loss has just been approved by the Food and Drug Administration (FDA). The treatment, Otarmeni (lunsotogene parvec-cwha), is the first-ever dual adeno-associated ...
Children born deaf because of a rare condition can now take a drug to restore their hearing after a gene therapy was approved in the U.S., ushering in a new era for the treatment of an inherited form ...
The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. Limited time: Save 25% on NBC News subscription Get exclusive reporting, ...
April 23 (Reuters) - The U.S. Food and Drug Administration has approved Regeneron's (REGN.O), opens new tab gene therapy for a rare genetic form of deafness, the company said on Thursday. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results